|
Building on research studies completed in 2004 and 2007, The Role of Distributors in the U.S. Healthcare Industry, conducted by Booz & Company, analyzes the dynamics affecting the healthcare supply chain in the past four years, and provides a qualitative and quantitative view of the unique services and value traditional distributors provide to the U.S. healthcare system.
According to the study, there has been a five percent growth in pharmaceutical sales revenues through primary distributors, who handle 87 percent of the total $307 billion market, up from 82 percent in 2006. Traditional, primary distributors specifically account for 79 percent of these figures (specialty pharmaceutical distributors account for the remainder). Distributors deliver products to 200,000 providers on a daily basis with fill rates exceeding 95 percent.
This study, which uses primary interviews with executives from across the healthcare supply chain, documents the value distributors deliver, as well as describes how pharmaceuticals flow through the supply chain, and sheds light on changes the industry has seen since the Center’s 2007 report.
View the press release
Purchase your copy
|